The black box warnings for the use of all TNF inhibitors include an increased risk of serious infections (i.e., tuberculosis, invasive fungal infections, and bacterial infections with opportunistic pathogens), as well as lymphoma and other malignancies, specifically, the rare hepatosplenic T cell lymphoma [20]. This evidence concerns the gene TNF and T-cell non-Hodgkin lymphoma.